<< Back To Authors

Overview

Liz Highleyman

Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.

Articles

Monkeypox Outbreak Sparks Worldwide Concern

Experts are urging gay and bi men, in particular, to report unusual skin rashes to a health care provider.

FDA Lifts Clinical Hold on Long-Acting Lenacapavir

The injectable antiretroviral could potentially be taken once every six months for HIV treatment or PrEP.

PrEP pills and injectable concept syringe

Prevention: PrEP Benefits

Some people say they find long-acting injections more convenient than daily pills, which could increase uptake and adherence.

Treatment: Lenacapavir

They started on lenacapavir pills and then switched to injections every six months plus an optimized back-ground regimen.

new york skyline at night red Empire State Building

Cure: Another Cure?

She has not experienced viral rebound and tests negative for HIV antibodies.

finger touching heart with heartbeat line

Concerns: Heart Risk

Previous research showed that HIV-positive people have higher rates of cardiovascular problems.

African American Black woman laughing on couch

HIV and Aging

Over half of people with HIV and 17% of those newly diagnosed are 50 and older.

Broadly Neutralizing Antibody Leads to Long-Term HIV Remission

One person treated with a broadly neutralizing antibody plus romidepsin remained in remission for 3.7 years.

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ

Close-up Of African Person Holding Blank Digital Tablet

Federal Government Releases Telehealth Guidelines for HIV Care

The guide lays out best practices for HIV prevention, diagnosis, treatment and monitoring.

Still Few Answers as Kids Hepatitis Outbreak Spreads

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

Broadly Neutralizing Antibodies Delay HIV Rebound

A combination of two antibodies, dubbed 3BNC117 and 10-1074, maintained viral suppression for a year in two people.

Vector illustration with a touch of 80’s style depicting COVID-19 concept

A Majority of People With HIV Have Asymptomatic COVID

The proportion without symptoms was higher than previously seen in many studies of both people with HIV and the general population.

Mysterious Hepatitis Outbreak Hitting Kids in U.K. and U.S.

The current leading suspect is an adenovirus, but much more remains to be learned.

Widely Used Meds Linked to Falls and Frailty in Older People With HIV

Anticholinergic medications can lead to cognitive problems and poor coordination, especially in older people.

New COVID Vaccine May Better Protect Cancer Patients

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

pregnancy, gynecology, medicine, health care and people concept - gynecologist doctor with stethoscope listening to pregnant woman baby heartbeat

Universal Hepatitis C Screening During Pregnancy Detects More Cases

Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.